NCT01100294View on ClinicalTrials.gov

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

Vaccination with FLUVAL P

"Vaccination with Fluval P monovalent influenza vaccine with 6 μg HA/0.5 ml active ingredient content and aluminium phosphate gel adjuvant.~Dose: 0.25 ml (total 3 μg HA), single dose."

Trial Locations (1)

8200

"Csolnoky Ferenc Veszprém County Hospital", Veszprém

Sponsors
All Listed Sponsors
lead

Fluart Innovative Vaccine Ltd, Hungary

INDUSTRY